You are here
- Home
- Therapy Areas
- Oncology/Infection
A Phase II, Open, Randomised Study to Assess the Efficacy and Safety of AZD6244 Versus Pemetrexed (Alimta) in Patients With Non-Small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen
- Disease
- solid tumour
- Drug Name
- AZD6244
- Generic Name
- AZD6244
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Aug 22, 2006
- Study Name
- D1532C00012
- Study Id
- D1532C00012
- ClinicalTrials.gov ID
- NCT00372788
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
